Radiology Technologists’ Pivotal Role in Early Detection and Systematic Escalation of Incidental Critical Findings During Imaging Procedures

Authors

  • Althobaity, Mohammed Khader A
  • Laila Saleh Aldhahri
  • Alenezi Saeidah Eid H
  • Mansour, Muteb Aedh S
  • Alenezi, Salem Aswaid S
  • Alnami, Hassan Ahmed Y
  • Alanazi, Yousef Sahud M
  • Badr Sulaiman Hamed Almuzaini
  • Mustafa Abdullah Essa Alhamaqi
  • Bader Muadhib A Alruwaili

DOI:

https://doi.org/10.22399/ijcesen.4739

Keywords:

Radiology Technologist, Incidental Critical Findings, Early Detection, Escalation Protocol, Patient Safety, Image Surveillance

Abstract

Radiology Technologists (RTs) serve as critical frontline safeguards in modern diagnostic imaging, playing an indispensable role in the early detection and urgent escalation of incidental critical findings (ICFs). During imaging procedures, RTs conduct real-time image surveillance, utilizing systematic search patterns, anatomical knowledge, and clinical context to identify potentially life-threatening abnormalities—such as large hemorrhages, aortic dissections, or tension pneumothoraxes—that are unrelated to the primary exam indication. This proactive detection triggers a mandated escalation protocol, requiring immediate, direct communication to the interpreting radiologist to ensure timely clinical intervention. Fulfilling this responsibility successfully hinges on robust institutional policies, interdisciplinary collaboration, and a supportive safety culture that empowers RTs to act. Ultimately, by bridging the gap between image acquisition and formal interpretation, RTs transform from technical operators into vital patient advocates, directly enhancing outcomes and strengthening the entire diagnostic safety net within healthcare.

References

1. Adams SJ, Rakheja R, Bryce R, Babyn PS (2018) Incidence and economic impact of incidental findings on 18F-FDG PET/CT imaging. Can Assoc Radiol J 69(1):63–70.

2. Chen W, Li Y, Li Z, Jiang Y, Cui Y, Zeng J, Mo Y, Tang S, Li S, Liu L, Zhao Y, Hu Y, Fan W (2024) Advantages and challenges of total-body PET/CT at a tertiary cancer center insights from Sun Yat-sen University cancer center. J Nucl Med 65(Supplement 1):54S-63S.

3. Daube-Witherspoon ME, Pantel AR, Pryma DA, Karp JS (2022) Total-body PET: a new paradigm for molecular imaging. Br J Radiol 95(1140):20220357.

4. Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, Tang S, Deng Z, Dong Y, Lv Y, Bao J, Liu W, Li H, Jones T, Badawi RD, Cherry SR (2021) Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2–2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View. J Nucl Med 62(6):861–870.

5. Zhao L, Fang Q (2016) Recent advances in the noninvasive strategies of cardiac amyloidosis. Heart Fail Rev 21:703–721.

6. Vanderschaeghe G, Schaeverbeke J, Bruffaerts R, Vandenberghe R, Dierickx K (2018) From information to follow-up: ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting. Alzheimer’s Dementia Transl Res Clin Intervent 4(1):243–251.

7. Graham M, Hallowell N, Savulescu J (2021) A just standard: the ethical management of incidental findings in brain imaging research. J Law Med Ethics 49(2):269–281.

8. Kirschen MP, Jaworska A, Illes J (2006) Subjects’ expectations in neuroimaging research. J Magn Reson Imaging 23(2):205–209.

9. Pijl JP, Nienhuis PH, Kwee TC, Glaudemans AW, Slart RH, Gormsen LC (2021) Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation. Semin Nucl Med 51(6):633–645.

10. Bertolini V, Palmieri A, Bassi MC, Bertolini M, Trojani V, Piccagli V, Fioroni F, Cavuto S, Guberti M, Versari A, Cola S (2020) CT protocol optimisation in PET/CT: a systematic review. EJNMMI Phys 7(17).

11. Mostafapour S, Greuter M, van Snick JH, Brouwers AH, Dierckx R, van Sluis J, Lammertsma AA, Tsoumpas C (2024) Ultra-low dose CT scanning for PET/CT. Med Phys 51(1):139–155.

12. Huang Y, Wang M, Jiang L, Wang L, Chen L, Wang Q, Feng J, Wang J, Xu W, Wu H, Han Y (2023) Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans. EJNMMI Phys 10(14).

13. Bentestuen M, Gossili F, Almasi CE, Zacho HD (2022) Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature. Cancer Imaging 22(44).

14. Seleiro E, Scélo G, Scoccianti C, Storm H, Vineis P, Fervers B (2018) Discussion paper of the IARC ethics committee on the management of incidental findings in genomic research studies. Int Agency Res Cancer 1.

15. Kwee TC, Yakar D, Sluijter TE, Pennings JP, Roest C (2023) Can we revolutionize diagnostic imaging by keeping Pandora’s box closed? Br J Radiol 96(1152):20230505.

16. Morin S, Cobbold J, Lim A, Eliahoo J, Thomas E, Mehta S, Durighel G, Fitzpatrick J, Bell J, Taylor-Robinson S (2009) Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol 72(3):529–533.

17. Casselden E, Sheerin F, Winter SC (2019) Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer. Eur Arch Otorhinolaryngol 276:243–247.

18. O’Sullivan JW, Muntinga T, Grigg S, Ioannidis JPA (2018) Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ 361.

19. Chalampalakis Z, Stute S, Filipovi’c M, Sureau F, Comtat C (2021) Use of dynamic reconstruction for parametric patlak imaging in dynamic whole body pet. Phys Med Biol 66(18):185017.

20. Prenosil GA, Sari H, Fürstner M, Afshar-Oromieh A, Shi K, Rominger A, Hentschel M (2022) Performance characteristics of the biograph vision quadra PET/CT system with a long axial field of view using the NEMA NU 2–2018 standard. J Nucl Med 63(3):476–484.

21. RCR (2011) Management of incidental findings detected during research imaging. Lond R Coll Radiol 1:1–60.

22. Schaare D, Ward L D and Boccuto L (2022). Incidental findings in study participants: what is the researcher’s obligation? Genes 13(10).

23. Hicks RJ, Ware RE, Callahan J (2024) Total-body PET/CT: pros and cons. Semin Nuclear Med.

24. National Health and Medical Research Council (2023) National statement on ethical conduct in human research. Australian Government pp 1–114.

25. Brodersen J, Voss T, Martiny F, Siersma V, Barratt A, Heleno B (2020) Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials. Breathe 16(1).

26. Scott IA, Slavotinek J, Glasziou PP (2024) First do no harm in responding to incidental imaging findings. Med J Aust 220(1):7–9.

27. Bunnik E M, van Bodegom L, Pinxten W, de Beaufort ID, Vernooij MW (2017) Ethical framework for the detection, management and communication of incidental findings in imaging studies, building on an interview study of researchers’ practices and perspectives. BMC Med Ethics 18(10).

28. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, Fletcher JG, Georgieff MK, Hammerschmidt D, Hudson K et al (2008) Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 36(2):219–248.

29. Wardlaw JM, Davies H, Booth TC, Laurie G, Compston A, Freeman C, Leach MO, Waldman AD, Lomas DJ, Kessler K, Crabbe F, Jackson A (2015) Acting on incidental findings in research imaging. BMJ 351.

30. Koplin JJ, Turner MR, Savulescu J (2020) The duty to look for incidental findings in imaging research. Ethics Hum Res 42(2):2–12.

31. Ng Q, Triumbari E, Omidvari N, Cherry SR, Badawi RD, Nardo L (2022) Total-body PET/CT - first clinical experiences and future perspectives. Semin Nucl Med 52(3):330–339.

32. Prieto E, García-Velloso MJ, Aquerreta JD, Rosales JJ, Bastidas JF, Soriano I, Irazola L, Rodríguez-Otero P, Quincoces G, Martí-Climent JM (2021) Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma. Physica Med 84:1–9.

33. Siva S, Udovicich C, Tran B, Zargar H, Murphy DG, Hofman MS (2020) Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer. Nat Rev Urol 17.

34. Booth TC, Waldman AD, Wardlaw JM, Taylor SA, Jackson A (2014) Management of incidental findings during imaging research in “healthy’’ volunteers: current UK practice. Br J Radiol 85(1009):11–21.

35. Pini C, Ninatti G, Gelardi F, Sollini M, Chiti A (2024) Cutting back on overdiagnosis - Occam’s Razor and unspecific bone uptakes in PSMA PET. Eur J Nucl Med Mol Imaging 51(6):3765–3766.

36. Booth TC, Jackson A, Wardlaw JM, Taylor SA, Waldman AD (2014) Incidental findings found in “healthy’’ volunteers during imaging performed for research: current legal and ethical implications. Br J Radiol 83(990):456–465.

37. Ganguli I, Simpkin AL, Lupo C, Weissman A, Mainor AJ, Orav EJ, Rosenthal MB, Colla CH, Sequist TD (2019) Cascades of care after incidental findings in a US national survey of physicians. JAMA Netw Open 2(10):e1913325–e1913325.

38. Genovesi D, Vergaro G, Giorgetti A, Marzullo P, Scipioni M, Santarelli MF, Pucci A, Buda G, Volpi E, Emdin M (2021) [18F]-Florbetaben PET/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions. JACC Cardiovasc Imaging 14(1):246–255.

Downloads

Published

2024-07-30

How to Cite

Althobaity, Mohammed Khader A, Laila Saleh Aldhahri, Alenezi Saeidah Eid H, Mansour, Muteb Aedh S, Alenezi, Salem Aswaid S, Alnami, Hassan Ahmed Y, … Bader Muadhib A Alruwaili. (2024). Radiology Technologists’ Pivotal Role in Early Detection and Systematic Escalation of Incidental Critical Findings During Imaging Procedures. International Journal of Computational and Experimental Science and Engineering, 10(4). https://doi.org/10.22399/ijcesen.4739

Issue

Vol. 10 No. 4 (2024): IJCESEN

Section

Research Article

License

Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.